Cargando…
Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrot...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277480/ https://www.ncbi.nlm.nih.gov/pubmed/35845986 http://dx.doi.org/10.3389/fphys.2022.948094 |
_version_ | 1784745991359954944 |
---|---|
author | Liu, Feng Chen, Jiefang Luo, Changqing Meng, Xianfang |
author_facet | Liu, Feng Chen, Jiefang Luo, Changqing Meng, Xianfang |
author_sort | Liu, Feng |
collection | PubMed |
description | MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrotic syndrome. Despite decades of research, the exact pathogenesis of podocytopathies remains incompletely understood and effective therapies are still lacking. An increasing body of evidence has revealed a critical role of miRNAs dysregulation in the onset and progression of podocytopathies. Moreover, several lines of research aimed at improving common podocytopathies diagnostic tools and avoiding invasive kidney biopsies have also identified circulating and urine miRNAs as possible diagnostic and prognostic biomarkers for podocytopathies. The present review mainly aims to provide an updated overview of the recent achievements in research on the potential applicability of miRNAs involved in renal disorders related to podocyte dysfunction by laying particular emphasis on focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD) and IgA nephropathy (IgAN). Further investigation into these dysregulated miRNAs will not only generate novel insights into the mechanisms of podocytopathies, but also might yield novel strategies for the diagnosis and therapy of this disease. |
format | Online Article Text |
id | pubmed-9277480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92774802022-07-14 Pathogenic Role of MicroRNA Dysregulation in Podocytopathies Liu, Feng Chen, Jiefang Luo, Changqing Meng, Xianfang Front Physiol Physiology MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrotic syndrome. Despite decades of research, the exact pathogenesis of podocytopathies remains incompletely understood and effective therapies are still lacking. An increasing body of evidence has revealed a critical role of miRNAs dysregulation in the onset and progression of podocytopathies. Moreover, several lines of research aimed at improving common podocytopathies diagnostic tools and avoiding invasive kidney biopsies have also identified circulating and urine miRNAs as possible diagnostic and prognostic biomarkers for podocytopathies. The present review mainly aims to provide an updated overview of the recent achievements in research on the potential applicability of miRNAs involved in renal disorders related to podocyte dysfunction by laying particular emphasis on focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD) and IgA nephropathy (IgAN). Further investigation into these dysregulated miRNAs will not only generate novel insights into the mechanisms of podocytopathies, but also might yield novel strategies for the diagnosis and therapy of this disease. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277480/ /pubmed/35845986 http://dx.doi.org/10.3389/fphys.2022.948094 Text en Copyright © 2022 Liu, Chen, Luo and Meng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Liu, Feng Chen, Jiefang Luo, Changqing Meng, Xianfang Pathogenic Role of MicroRNA Dysregulation in Podocytopathies |
title | Pathogenic Role of MicroRNA Dysregulation in Podocytopathies |
title_full | Pathogenic Role of MicroRNA Dysregulation in Podocytopathies |
title_fullStr | Pathogenic Role of MicroRNA Dysregulation in Podocytopathies |
title_full_unstemmed | Pathogenic Role of MicroRNA Dysregulation in Podocytopathies |
title_short | Pathogenic Role of MicroRNA Dysregulation in Podocytopathies |
title_sort | pathogenic role of microrna dysregulation in podocytopathies |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277480/ https://www.ncbi.nlm.nih.gov/pubmed/35845986 http://dx.doi.org/10.3389/fphys.2022.948094 |
work_keys_str_mv | AT liufeng pathogenicroleofmicrornadysregulationinpodocytopathies AT chenjiefang pathogenicroleofmicrornadysregulationinpodocytopathies AT luochangqing pathogenicroleofmicrornadysregulationinpodocytopathies AT mengxianfang pathogenicroleofmicrornadysregulationinpodocytopathies |